Recent evidence suggests that IL-1β has a dual role in cancer development: On the one hand, it initiated pro-inflammatory anti-tumor immune responses by activating tumor antigen-specific TH1 and TH17 cells and facilitated tumor regression (233). This evidence concerns the gene IL1B and neoplasm.